Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Busby

Showing results (61-70 of 110) with videos related to

Pageof 11
Sort By:
The Journal of Allergy and Clinical Immunology. in Practice|October 9, 2021
Ethnic Differences in Severe Asthma Clinical Care and Outcomes: An Analysis of United Kingdom Primary and Specialist CareJohn Busby, Liam G Heaney, Thomas Brown, et al.
The Journal of Allergy and Clinical Immunology|August 3, 2024
Airway proteomics reveals broad residual anti-inflammatory effects of prednisolone in mepolizumab-treated asthmaImran Howell, Freda Yang, Vanessa Brown, et al.
The European Respiratory Journal|June 20, 2024
Clinical remission with biologic therapies in severe asthma: a matter of definition, P Jane McDowell, Ron McDowell, et al.
The European Respiratory Journal|October 19, 2023
Clinical remission in severe asthma with biologic therapy: an analysis from the UK Severe Asthma RegistryP Jane McDowell, Ron McDowell, John Busby, et al.
The Journal of Allergy and Clinical Immunology. in Practice|July 20, 2024
Clinical and Economic Burden of Severe Asthma With Low Blood Eosinophil CountsJohn Busby, Shruti Menon, Neil Martin, et al.
ERJ Open Research|June 3, 2026
Adverse outcomes in young adults with severe asthma: results from the UK Severe Asthma RegistryLeanne-Jo Holmes, Charlene Redmond, Liam Heaney, et al.
The Journal of Allergy and Clinical Immunology. in Practice|May 2, 2025
Exploring the Long-Term Utility of Remotely Monitored FeNO Suppression Testing in Severe AsthmaJohn Busby, Joshua Holmes, Mohammed Almutairi, et al.
Critical Care Explorations|April 21, 2026
The Effects of Conservative Fluid Management and Active Deresuscitation on Markers of Tissue Perfusion, Kidney Injury, and Vascular Injury in Critically Ill Adults: A Secondary Analysis of the Role of Active Deresuscitation After Resuscitation-2 (RADAR-2) TrialRoss R McMullan, Christopher McGrath, Neil Cody, et al.
The Journal of Allergy and Clinical Immunology. in Practice|August 3, 2025
Effects of obesity on response to asthma biologic treatment: Longitudinal data from the United Kingdom Severe Asthma RegistrySherif Gonem, Charlene Redmond, John Busby, et al.
ERJ Open Research|August 28, 2025
Urinary thromboxane and isoprostane levels are elevated in symptom-high T2-biomarker-low severe asthmaMatthew Chad Eastwood, John Busby, Johan Kolmert, et al.
Pageof 11

Showing results (61-70 of 110) with videos related to

Sort By:
Pageof 11
The Journal of Allergy and Clinical Immunology. in Practice|October 9, 2021
Ethnic Differences in Severe Asthma Clinical Care and Outcomes: An Analysis of United Kingdom Primary and Specialist CareJohn Busby, Liam G Heaney, Thomas Brown, et al.
The Journal of Allergy and Clinical Immunology|August 3, 2024
Airway proteomics reveals broad residual anti-inflammatory effects of prednisolone in mepolizumab-treated asthmaImran Howell, Freda Yang, Vanessa Brown, et al.
The European Respiratory Journal|June 20, 2024
Clinical remission with biologic therapies in severe asthma: a matter of definition, P Jane McDowell, Ron McDowell, et al.
The European Respiratory Journal|October 19, 2023
Clinical remission in severe asthma with biologic therapy: an analysis from the UK Severe Asthma RegistryP Jane McDowell, Ron McDowell, John Busby, et al.
The Journal of Allergy and Clinical Immunology. in Practice|July 20, 2024
Clinical and Economic Burden of Severe Asthma With Low Blood Eosinophil CountsJohn Busby, Shruti Menon, Neil Martin, et al.
ERJ Open Research|June 3, 2026
Adverse outcomes in young adults with severe asthma: results from the UK Severe Asthma RegistryLeanne-Jo Holmes, Charlene Redmond, Liam Heaney, et al.
The Journal of Allergy and Clinical Immunology. in Practice|May 2, 2025
Exploring the Long-Term Utility of Remotely Monitored FeNO Suppression Testing in Severe AsthmaJohn Busby, Joshua Holmes, Mohammed Almutairi, et al.
Critical Care Explorations|April 21, 2026
The Effects of Conservative Fluid Management and Active Deresuscitation on Markers of Tissue Perfusion, Kidney Injury, and Vascular Injury in Critically Ill Adults: A Secondary Analysis of the Role of Active Deresuscitation After Resuscitation-2 (RADAR-2) TrialRoss R McMullan, Christopher McGrath, Neil Cody, et al.
The Journal of Allergy and Clinical Immunology. in Practice|August 3, 2025
Effects of obesity on response to asthma biologic treatment: Longitudinal data from the United Kingdom Severe Asthma RegistrySherif Gonem, Charlene Redmond, John Busby, et al.
ERJ Open Research|August 28, 2025
Urinary thromboxane and isoprostane levels are elevated in symptom-high T2-biomarker-low severe asthmaMatthew Chad Eastwood, John Busby, Johan Kolmert, et al.
Pageof 11